2023 Form 5500 filing — Sigmapharm Laboratories, LLC 401(K) Profit Sharing Plan And Trust

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241004135751NAL0022860914001) for Sigmapharm Laboratories, LLC 401(K) Profit Sharing Plan And Trust, reported by Sigmapharm Laboratories, LLC under EIN 20-2433641 and plan number 001. It reports 176 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241004135751NAL0022860914001
Filing year
2023
Form type
2
Plan sponsor
Sigmapharm Laboratories, LLC
EIN
20-2433641
Plan number
001
Location
Bensalem, PA
Participants
176
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$10,226,540
Total liabilities (EOY)
$0
Net assets (EOY)
$10,226,540
Employer contributions
$270,471
Participant contributions
$691,473
Total income / additions
$2,704,691
Benefits paid
$1,035,242
Administrative expenses
$38,408
Total expenses
$1,073,650
Net increase / (decrease)
$1,631,041
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Resources Investment Advisors LLCADVISOR$22,091not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER$16,317not reported in the loaded dataset

Related Form 5500 pages